Literature DB >> 23583439

Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.

H Eriksson1, J Lyth, E Månsson-Brahme, M Frohm-Nilsson, C Ingvar, C Lindholm, P Naredi, U Stierner, G Wagenius, J Carstensen, J Hansson.   

Abstract

BACKGROUND: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden.
METHODS: We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010.
RESULTS: The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I=1.6; 95% confidence interval (CI)=1.5-1.7. OR stage III-IV versus I=2.3; 95% CI=1.8-2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high=2.02; 95% CI=1.80-2.26; p<0.0001) and intermediate (HR intermediate versus high=1.35; 95% CI=1.20-1.51; p<0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR=1.13; 95% CI=1.01-1.27; p=0.04) but not for intermediate versus high (HR=1.11; 95% CI=0.99-1.24; p=0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55 years, patients with truncal tumours and during the first 5 years after diagnosis.
CONCLUSION: Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Level of education; Melanoma; Population-based; Socioeconomic status; Stage at diagnosis; Survival

Mesh:

Year:  2013        PMID: 23583439     DOI: 10.1016/j.ejca.2013.03.013

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

1.  Impact of rurality on processes and outcomes in melanoma care: results from a whole-Scotland melanoma cohort in primary and secondary care.

Authors:  Peter Murchie; Rosalind Adam; Wei L Khor; Edwin A Raja; Lisa Iversen; David H Brewster; Amanda J Lee
Journal:  Br J Gen Pract       Date:  2018-06-18       Impact factor: 5.386

2.  Disparities in diagnosis of advanced melanoma: a population-based cohort study.

Authors:  Meaghan E Mavor; Harriet Richardson; Qun Miao; Yuka Asai; Timothy P Hanna
Journal:  CMAJ Open       Date:  2018-10-31

3.  Survival of sentinel node biopsy versus observation in intermediate-thickness melanoma: A Dutch population-based study.

Authors:  R M H Roumen; M S Schuurman; M J Aarts; A J G Maaskant-Braat; G Vreugdenhil; W J Louwman
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

4.  Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review.

Authors:  Nina Afshar; Dallas R English; Roger L Milne
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

5.  Late-Stage Melanoma: Be Sure to Screen Uninsured, Unmarried Men.

Authors:  Virginia L Valentin; Wayne Sanderson; Susan Westneat; Eric Durbin
Journal:  South Med J       Date:  2018-11       Impact factor: 0.810

Review 6.  Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.

Authors:  Fernanda Costa Svedman; Demetris Pillas; Aliki Taylor; Moninder Kaur; Ragnar Linder; Johan Hansson
Journal:  Clin Epidemiol       Date:  2016-05-26       Impact factor: 4.790

7.  Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study.

Authors:  Amr Makady; Rachel R J Kalf; Bettina Ryll; Gilliosa Spurrier; Anthonius de Boer; Hans Hillege; Olaf H Klungel; Wim Goettsch
Journal:  Health Qual Life Outcomes       Date:  2018-11-29       Impact factor: 3.186

8.  Temporal Trends in the Incidence and Mortality of Skin Malignant Melanoma in China from 1990 to 2019.

Authors:  Ruhai Bai; Hui Huang; Minmin Li; Meng Chu
Journal:  J Oncol       Date:  2021-08-24       Impact factor: 4.375

9.  Socioeconomic differences in cancer survival among Swedish children.

Authors:  Hanna Mogensen; Karin Modig; Giorgio Tettamanti; Mats Talbäck; Maria Feychting
Journal:  Br J Cancer       Date:  2016-01-05       Impact factor: 7.640

10.  Influence of socioeconomic factors and region of residence on cancer stage of malignant melanoma: a Danish nationwide population-based study.

Authors:  Else Helene Ibfelt; Marianne Steding-Jessen; Susanne Oksbjerg Dalton; Sanne Lykke Lundstrøm; Merete Osler; Lisbet Rosenkrantz Hölmich
Journal:  Clin Epidemiol       Date:  2018-07-10       Impact factor: 4.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.